Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ruiz

Showing results (641-650 of 671) with videos related to

Pageof 68
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 2, 2026
High Accuracy in Patient Self-Reporting of Keratinocyte Carcinoma, but Reduced Sensitivity for Squamous Cell Carcinoma: A Multicenter StudyAshley Riddle, Cassidy M Nguyen, Emily Karn, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancerAnn W Silk, Christopher A Barker, Shailender Bhatia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
JAMA Dermatology|July 24, 2024
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCCShayan Cheraghlou, Mary L Stevenson, Sean R Christensen, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Prognostic determinants of early and late relapse in cutaneous squamous cell carcinoma: a multicenter retrospective cohort studySergio Rodríguez-Conde, Cristian D Cardona-Machado, Nina A Ran, et al.
Journal of the American Academy of Dermatology|March 2, 2025
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinomaAnokhi Jambusaria-Pahlajani, Vincent Jeanselme, David M Wang, et al.
Journal of Applied Microbiology|August 23, 2025
Natural products eugenol and cinnamaldehyde as potential therapeutic alternatives against Candida auris infectionsDébora S M de Sousa, Gabrielle P M Monari, Cassiana F da Rosa, et al.
Journal of the American Academy of Dermatology|October 7, 2025
Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 yearsEmily S Ruiz, Eva Muñoz-Couselo, Henri Montaudié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
Journal of Surgical Oncology|July 12, 2026
Prognostic Factors in Primary Head and Neck Cutaneous Squamous Cell Carcinoma: A Large-Scale, Multi-Institutional Competing-Risks AnalysisFábio Muradás Girardi, Cristian David Cardona Machado, Ashley Wysong, et al.
Pageof 68

Showing results (641-650 of 671) with videos related to

Sort By:
Pageof 68
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 2, 2026
High Accuracy in Patient Self-Reporting of Keratinocyte Carcinoma, but Reduced Sensitivity for Squamous Cell Carcinoma: A Multicenter StudyAshley Riddle, Cassidy M Nguyen, Emily Karn, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancerAnn W Silk, Christopher A Barker, Shailender Bhatia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Excision With Total Margin Control Versus Vertical Section Margin Assessment for NCCN Very High-Risk Cutaneous Squamous Cell CarcinomaDavid M Wang, Nina A Ran, Emily E Granger, et al.
JAMA Dermatology|July 24, 2024
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCCShayan Cheraghlou, Mary L Stevenson, Sean R Christensen, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Prognostic determinants of early and late relapse in cutaneous squamous cell carcinoma: a multicenter retrospective cohort studySergio Rodríguez-Conde, Cristian D Cardona-Machado, Nina A Ran, et al.
Journal of the American Academy of Dermatology|March 2, 2025
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinomaAnokhi Jambusaria-Pahlajani, Vincent Jeanselme, David M Wang, et al.
Journal of Applied Microbiology|August 23, 2025
Natural products eugenol and cinnamaldehyde as potential therapeutic alternatives against Candida auris infectionsDébora S M de Sousa, Gabrielle P M Monari, Cassiana F da Rosa, et al.
Journal of the American Academy of Dermatology|October 7, 2025
Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 yearsEmily S Ruiz, Eva Muñoz-Couselo, Henri Montaudié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
Journal of Surgical Oncology|July 12, 2026
Prognostic Factors in Primary Head and Neck Cutaneous Squamous Cell Carcinoma: A Large-Scale, Multi-Institutional Competing-Risks AnalysisFábio Muradás Girardi, Cristian David Cardona Machado, Ashley Wysong, et al.
Pageof 68